• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用一个简单的模型估算美国六个州开展的新冠病毒疫苗接种活动挽救的生命数量。

Estimate the number of lives saved by a SARS-CoV-2 vaccination campaign in six states in the United States with a simple model.

作者信息

Yin Yi, Tang Shuhan, Li Qiong, Zhou Sijia, Ma Yuhang, Wang Weiming, He Daihai, Peng Zhihang

机构信息

School of Public Health, Nanjing Medical University, Nanjing, China.

Beijing Normal University-Hong Kong Baptist University United International College, Zhuhai, China.

出版信息

IJID Reg. 2024 Jun 15;12:100390. doi: 10.1016/j.ijregi.2024.100390. eCollection 2024 Sep.

DOI:10.1016/j.ijregi.2024.100390
PMID:39041059
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11262167/
Abstract

OBJECTIVES

Vaccination and the emergence of the highly transmissible Omicron variant changed the fate of the COVID-19 pandemic. It is very challenging to estimate the number of lives saved by vaccination given the multiple doses of vaccination, the time-varying nature of transmissibility, the waning of immunity, and the presence of immune evasion.

METHODS

We established a S-S-E-I-T-D-R model to simulate the number of lives saved by vaccination in six states in the United States (U.S.) from March 5, 2020, to March 23, 2023. The cumulative number of deaths were estimated under three vaccination scenarios based on two assumptions. Additionally, immune evasion by the Omicron and loss of protection afforded by vaccination or infection were considered.

RESULTS

The number of deaths averted by COVID-19 vaccinations (including three doses) ranged from 0.154-0.295% of the total population across six states. The number of deaths averted by the third dose ranged from 0.008-0.017% of the total population.

CONCLUSIONS

Our estimate of death averted by COVID-19 vaccination in the U.S. was largely in line with an official estimate (at a level of 0.15-0.20% of the total population). We found that the additional contribution of the third dose was small but significant.

摘要

目的

疫苗接种以及高传播性奥密克戎变种的出现改变了新冠疫情的走向。鉴于疫苗接种的多剂次、传播性的时变特性、免疫力的减弱以及免疫逃逸的存在,估计疫苗接种挽救的生命数量极具挑战性。

方法

我们建立了一个S-S-E-I-T-D-R模型,以模拟2020年3月5日至2023年3月23日期间美国六个州疫苗接种挽救的生命数量。基于两个假设,在三种疫苗接种情景下估计了累计死亡人数。此外,还考虑了奥密克戎的免疫逃逸以及疫苗接种或感染所提供保护的丧失。

结果

新冠疫苗接种(包括三剂)避免的死亡人数占六个州总人口的0.154%-0.295%。第三剂疫苗避免的死亡人数占总人口的0.008%-0.017%。

结论

我们对美国新冠疫苗接种避免的死亡人数的估计在很大程度上与官方估计一致(占总人口的0.15%-0.20%)。我们发现第三剂疫苗的额外贡献虽小但很显著。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73d1/11262167/0b4455d60f48/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73d1/11262167/8883b2a378f9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73d1/11262167/021b7b12c533/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73d1/11262167/0b4455d60f48/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73d1/11262167/8883b2a378f9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73d1/11262167/021b7b12c533/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73d1/11262167/0b4455d60f48/gr3.jpg

相似文献

1
Estimate the number of lives saved by a SARS-CoV-2 vaccination campaign in six states in the United States with a simple model.用一个简单的模型估算美国六个州开展的新冠病毒疫苗接种活动挽救的生命数量。
IJID Reg. 2024 Jun 15;12:100390. doi: 10.1016/j.ijregi.2024.100390. eCollection 2024 Sep.
2
COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.印度的新冠疫情动态、严重急性呼吸综合征冠状病毒2(SARS-CoV-2)德尔塔变异株及其对疫苗接种的影响
medRxiv. 2021 Nov 22:2021.06.21.21259268. doi: 10.1101/2021.06.21.21259268.
3
Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.疫苗对 Alpha、Delta 或奥密克戎变异株引起的 SARS-CoV-2 感染或 COVID-19 住院的有效性:一项全国性丹麦队列研究。
PLoS Med. 2022 Sep 1;19(9):e1003992. doi: 10.1371/journal.pmed.1003992. eCollection 2022 Sep.
4
Estimated COVID-19 severe cases and deaths averted in the first year of the vaccination campaign in Brazil: A retrospective observational study.巴西疫苗接种运动第一年避免的估计新冠重症病例和死亡:一项回顾性观察研究。
Lancet Reg Health Am. 2023 Jan;17:100418. doi: 10.1016/j.lana.2022.100418. Epub 2022 Dec 22.
5
COVID-19 hospitalizations and deaths averted under an accelerated vaccination program in northeastern and southern regions of the USA.美国东北部和南部地区加速疫苗接种计划避免的新冠住院和死亡情况。
Lancet Reg Health Am. 2022 Feb;6:100147. doi: 10.1016/j.lana.2021.100147. Epub 2021 Dec 29.
6
Benefit-Cost Analysis of the HHS COVID-19 Campaign: April 2021-March 2022.卫生与公众服务部 COVID-19 运动的效益-成本分析:2021 年 4 月至 2022 年 3 月。
Am J Prev Med. 2024 Aug;67(2):258-264. doi: 10.1016/j.amepre.2024.03.018. Epub 2024 May 6.
7
Conversations With Individuals on the Fence about CV-19 Vaccination: Analysis of Lives Saved by Vaccine vs. Natural Infection Mortality and Other Reflections.与对新冠疫苗接种持观望态度者的对话:疫苗挽救的生命与自然感染死亡率对比分析及其他思考
J Community Hosp Intern Med Perspect. 2022 Jan 31;12(1):1-6. doi: 10.55729/2000-9666.1000. eCollection 2022.
8
Estimating the impact of implementation and timing of the COVID-19 vaccination programme in Brazil: a counterfactual analysis.评估巴西新冠疫苗接种计划的实施及时间安排的影响:一项反事实分析。
Lancet Reg Health Am. 2023 Jan;17:100397. doi: 10.1016/j.lana.2022.100397. Epub 2022 Nov 21.
9
Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study.在以色列全国范围内使用辉瑞-生物科技公司的 BNT162b2 mRNA COVID-19 疫苗进行疫苗接种运动,以预防感染、住院和死亡:一项回顾性监测研究。
Lancet Infect Dis. 2022 Mar;22(3):357-366. doi: 10.1016/S1473-3099(21)00566-1. Epub 2021 Sep 22.
10
Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review.奥密克戎变异株与新冠前变异株相比,既往感染 SARS-CoV-2 在预防再感染和 COVID-19 严重并发症方面的作用:系统评价。
BMC Infect Dis. 2023 Jun 26;23(1):432. doi: 10.1186/s12879-023-08328-3.

引用本文的文献

1
Exploring affordable and effective pandemic containment measures in lower-income countries with a spatial SEIR model: a case study in South Africa.运用空间SEIR模型探索低收入国家经济适用且有效的疫情防控措施:以南非为例
BMC Public Health. 2025 Jul 23;25(1):2526. doi: 10.1186/s12889-025-23686-0.

本文引用的文献

1
Care fragmentation and readmission mortality and length of stay before and during the COVID-19 pandemic: data from the National Readmissions Database, 2018-2020.新冠疫情前后医疗碎片化与再入院死亡率和住院时间:来自国家再入院数据库的 2018-2020 年数据。
BMC Health Serv Res. 2024 May 14;24(1):622. doi: 10.1186/s12913-024-11073-1.
2
New insights into three trajectories of omicron-related all-cause death reduced by COVID-19 booster vaccination.奥密克戎相关全因死亡的三种轨迹在 COVID-19 加强针接种后减少的新见解。
J Infect Public Health. 2024 May;17(5):735-740. doi: 10.1016/j.jiph.2024.03.006. Epub 2024 Mar 6.
3
Omicron breakthrough infections after triple-dose inactivated COVID-19 vaccination: A comprehensive analysis of antibody and T-cell responses.
三剂新冠病毒灭活疫苗接种后出现的奥密克戎突破性感染:抗体和T细胞反应的综合分析
Immunology. 2024 Jun;172(2):313-327. doi: 10.1111/imm.13764. Epub 2024 Mar 10.
4
Protective effect of previous infection and vaccination against reinfection with BA.5 Omicron subvariant: a nationwide population-based study in Japan.既往感染和接种疫苗对BA.5奥密克戎亚变体再感染的保护作用:日本一项基于全国人群的研究
Lancet Reg Health West Pac. 2023 Sep 25;41:100911. doi: 10.1016/j.lanwpc.2023.100911. eCollection 2023 Dec.
5
Ethno-demographic disparities in humoral responses to the COVID-19 vaccine among healthcare workers.医护人员对 COVID-19 疫苗的体液免疫反应存在种族和人口统计学差异。
J Med Virol. 2023 Sep;95(9):e29067. doi: 10.1002/jmv.29067.
6
Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose.第三剂 COVID-19 mRNA 疫苗接种后针对奥密克戎变异株的持续 T 细胞介导的免疫应答。
Front Immunol. 2023 Jan 23;14:1099246. doi: 10.3389/fimmu.2023.1099246. eCollection 2023.
7
Third dose vaccination with mRNA-1273 or BNT162b2 vaccines improves protection against SARS-CoV-2 infection.使用mRNA-1273或BNT162b2疫苗进行第三剂接种可增强对SARS-CoV-2感染的防护力。
PNAS Nexus. 2022 Apr 28;1(2):pgac042. doi: 10.1093/pnasnexus/pgac042. eCollection 2022 May.
8
Mathematical assessment of the role of waning and boosting immunity against the BA.1 Omicron variant in the United States.美国针对奥密克戎BA.1变体的免疫力减弱和增强作用的数学评估。
Math Biosci Eng. 2023 Jan;20(1):179-212. doi: 10.3934/mbe.2023009. Epub 2022 Sep 30.
9
Twice evasions of Omicron variants explain the temporal patterns in six Asian and Oceanic countries.两次逃避奥密克戎变异解释了六个亚洲和大洋洲国家的时间模式。
BMC Infect Dis. 2023 Jan 13;23(1):25. doi: 10.1186/s12879-023-07984-9.
10
Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies.全球新兴的 SARS-CoV-2 奥密克戎变异株:影响、挑战与策略。
J Infect Public Health. 2023 Jan;16(1):4-14. doi: 10.1016/j.jiph.2022.11.024. Epub 2022 Nov 19.